NL-OMON49324已完成不适用
A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of LOU064 following a single dose of [14C]LOU064 administered orally or intravenouslyl in healthy male and female subjects at steady-state. - ADME of LOU064 following a single dose of [14C]LOU064
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female of non-childbearing potential.
- •18 - 55 years of age.
- •BMI 18.0 - 30.0 kilograms/meter2
- •non smokers
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of
- •participation in another drug study within 90 days before the start of this
- •study or being a blood donor within 60 days from the start of the study. In
- •case of donating more than 1.5 liters of blood in the 10 months prior the start
- •of this study.
研究者
相似试验
已完成
不适用
A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of QBW251 following a single oral dose of [14C]QBW251 in healthy male subjects at steady state conditions.ongaandoeningenCOPDlung diseasesNL-OMON46062ovartis Pharma AG6
已完成
不适用
A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of LNP023 following a single oral dose of [14C]LNP023 in healthy male/female subjects.NL-OMON48316ovartis6
已完成
不适用
A single-center, open-label study to evaluate the distribution, metabolism, and excretion (DME) and pharmacokinetics of MIJ821 following a single intravenous (i.v.) infusion of [14C]MIJ821 in healthy male participants.mental disorderNL-OMON51743ovartis6
已完成
不适用
A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of ZPL389 following a single oral dose of [14C]ZPL389 in healthy male subjects.atopic dermatitisNL-OMON46218ovartis Pharma AG6
已完成
不适用
A single-center, open-label study to evaluate the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of [14C]JDQ443 following a single oral dose of JDQ443 in healthy male participants.10027656CancerNL-OMON51491ovartis Pharma AG6